Dana Zhang has served as our Vice President of Finance and Board Secretary since 2018. Ms. Zhang’s career spans over 20 years of pharmaceutical industry and international business experience with an emphasis on long-term strategic planning, treasury management, process improvement, marketing partnerships, acquisitions and debt/equity financings. Ms. Zhang is responsible for global accounting and finance operations, tax planning and regulatory compliances, serves as Board Secretary, and is also a Board Director of Ambrx Australia. At Ambrx, Ms. Zhang teamed up with the CEO and executive team to successfully raise a US$200M oversubscribed crossover financing round with leading healthcare investors. Prior to joining Ambrx, Ms. Zhang was VP and Head of Finance for Kalypsys and held roles of increasing responsibility at AnaptysBio and BioDuro where she successfully closed multiple financings with hands-on IPO preparation.
Ms. Zhang is a Certified Public Accountant in California and earned a B.S. in Biology from Harbin Normal University in China, and an MBA in Finance from the University of Phoenix.